DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

Compare

529 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

XRAY Analyst Ratings

Hold

3 Buy

12 Hold

0 Sell

Based on 15 analysts giving stock ratings to

DENTSPLY

SIRONA

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

XRAY Stock 12 Month Forecast

Average Price Target

$16.65

▲(16.76% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $16.65 with a high forecast of $24.00 and a low forecast of $14.00. The average price target represents a 16.76% change from the last price of $14.26.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","19":"$19","26":"$26","15.5":"$15.5","22.5":"$22.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.65</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,15.5,19,22.5,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.3,15.046153846153846,15.792307692307693,16.53846153846154,17.284615384615385,18.03076923076923,18.776923076923076,19.52307692307692,20.26923076923077,21.015384615384615,21.76153846153846,22.50769230769231,23.253846153846155,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.3,14.480769230769232,14.661538461538463,14.842307692307692,15.023076923076923,15.203846153846154,15.384615384615385,15.565384615384614,15.746153846153845,15.926923076923076,16.107692307692307,16.288461538461537,16.46923076923077,{"y":16.65,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.3,14.276923076923078,14.253846153846155,14.230769230769232,14.207692307692309,14.184615384615386,14.161538461538463,14.138461538461538,14.115384615384615,14.092307692307692,14.069230769230769,14.046153846153846,14.023076923076923,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.82,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.42,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.38,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.82,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.26,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.6,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.22,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.79,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.46,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.54,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 37, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.3,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$24.00

Average Price Target$16.65

Lowest Price Target$14.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Steven Valiquette

Mizuho Securities

$17→$16

Hold

12.20%

Upside

Reiterated

08/14/25

Mizuho Securities Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

Michael Cherny

Leerink Partners

$17→$14.5

Hold

1.68%

Upside

Assigned

08/11/25

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (NASDAQ: TRVI), DENTSPLY SIRONA (NASDAQ: XRAY) and Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Rachel Vatnsdal

J.P. Morgan

$14

Hold

-1.82%

Downside

Reiterated

08/10/25

Analysts' Top Healthcare Picks: DENTSPLY SIRONA (XRAY), Replimune Group (REPL)

Jeff Johnson

Robert W. Baird

$20→$18

Hold

26.23%

Upside

Reiterated

08/08/25

Dentsply Sirona price target lowered to $18 from $20 at BairdDentsply Sirona price target lowered to $18 from $20 at Baird

Jonathan Block

Stifel Nicolaus

$19→$17

Hold

19.21%

Upside

Reiterated

08/08/25

DENTSPLY SIRONA (XRAY) Gets a Hold from Stifel Nicolaus

Kevin Caliendo

UBS

$25→$24

Buy

68.30%

Upside

Reiterated

08/08/25

Dentsply Sirona price target lowered to $24 from $25 at UBSDentsply Sirona price target lowered to $24 from $25 at UBS

Michael Petusky

Barrington

$21→$18

Buy

26.23%

Upside

Reiterated

08/08/25

Dentsply Sirona price target lowered to $18 from $21 at BarringtonDentsply Sirona price target lowered to $18 from $21 at Barrington

Vik Chopra

Wells Fargo

$16→$15

Hold

5.19%

Upside

Reiterated

08/08/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Wells FargoWells Fargo analyst Vik Chopra lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $15.00 (from $16.00) while maintaining a Equal Weight rating.

Erin Wright

Morgan Stanley

$14

Hold

-1.82%

Downside

Reiterated

08/07/25

DENTSPLY SIRONA: Hold Rating Amid Strong Earnings, Leadership Changes, and Market Challenges

David Saxon

Needham

―

Hold

―

Reiterated

08/07/25

DENTSPLY SIRONA: Hold Rating Maintained Amidst Mixed Performance and Promising Margin Improvements

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

08/07/25

William Blair Sticks to Their Buy Rating for DENTSPLY SIRONA (XRAY)

Michael Sarcone

Jefferies

$17→$15

Hold

5.19%

Upside

Reiterated

08/07/25

Jefferies Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)Jefferies analyst Brandon Couillard lowered the price target on DENTSPLY SIRONA (NASDAQ: XRAY) to $15.00 (from $17.00) while maintaining a Hold rating.

Elizabeth Anderson CFA

Evercore ISI

$17

Hold

19.21%

Upside

Reiterated

08/07/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Evercore ISI

Allen Lutz

Bank of America Securities

$17

Hold

19.21%

Upside

Reiterated

07/21/25

DENTSPLY SIRONA: Hold Rating Amid Leadership Changes and Strategic Uncertainty

Jason Bednar

Piper Sandler

$16→$17

Hold

19.21%

Upside

Reiterated

05/30/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Piper Sandler

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Steven Valiquette

Mizuho Securities

$17→$16

Hold

12.20%

Upside

Reiterated

08/14/25

Mizuho Securities Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

Michael Cherny

Leerink Partners

$17→$14.5

Hold

1.68%

Upside

Assigned

08/11/25

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (NASDAQ: TRVI), DENTSPLY SIRONA (NASDAQ: XRAY) and Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Rachel Vatnsdal

J.P. Morgan

$14

Hold

-1.82%

Downside

Reiterated

08/10/25

Analysts' Top Healthcare Picks: DENTSPLY SIRONA (XRAY), Replimune Group (REPL)

Jeff Johnson

Robert W. Baird

$20→$18

Hold

26.23%

Upside

Reiterated

08/08/25

Dentsply Sirona price target lowered to $18 from $20 at BairdDentsply Sirona price target lowered to $18 from $20 at Baird

Jonathan Block

Stifel Nicolaus

$19→$17

Hold

19.21%

Upside

Reiterated

08/08/25

DENTSPLY SIRONA (XRAY) Gets a Hold from Stifel Nicolaus

Kevin Caliendo

UBS

$25→$24

Buy

68.30%

Upside

Reiterated

08/08/25

Dentsply Sirona price target lowered to $24 from $25 at UBSDentsply Sirona price target lowered to $24 from $25 at UBS

Michael Petusky

Barrington

$21→$18

Buy

26.23%

Upside

Reiterated

08/08/25

Dentsply Sirona price target lowered to $18 from $21 at BarringtonDentsply Sirona price target lowered to $18 from $21 at Barrington

Vik Chopra

Wells Fargo

$16→$15

Hold

5.19%

Upside

Reiterated

08/08/25

Erin Wright

Morgan Stanley

$14

Hold

-1.82%

Downside

Reiterated

08/07/25

DENTSPLY SIRONA: Hold Rating Amid Strong Earnings, Leadership Changes, and Market Challenges

David Saxon

Needham

―

Hold

―

Reiterated

08/07/25

DENTSPLY SIRONA: Hold Rating Maintained Amidst Mixed Performance and Promising Margin Improvements

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

08/07/25

William Blair Sticks to Their Buy Rating for DENTSPLY SIRONA (XRAY)

Michael Sarcone

Jefferies

$17→$15

Hold

5.19%

Upside

Reiterated

08/07/25

Elizabeth Anderson CFA

Evercore ISI

$17

Hold

19.21%

Upside

Reiterated

08/07/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Evercore ISI

Allen Lutz

Bank of America Securities

$17

Hold

19.21%

Upside

Reiterated

07/21/25

DENTSPLY SIRONA: Hold Rating Amid Leadership Changes and Strategic Uncertainty

Jason Bednar

Piper Sandler

$16→$17

Hold

19.21%

Upside

Reiterated

05/30/25

DENTSPLY SIRONA (XRAY) Receives a Hold from Piper Sandler

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DENTSPLY SIRONA

1 Month

xxx

Success Rate

14/36 ratings generated profit

Average Return

-2.78%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 38.89% of your transactions generating a profit, with an average return of -2.78% per trade.

3 Months

xxx

Success Rate

11/36 ratings generated profit

Average Return

-5.91%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 30.56% of your transactions generating a profit, with an average return of -5.91% per trade.

1 Year

Michael PetuskyBarrington

Success Rate

5/36 ratings generated profit

Average Return

-23.08%

reiterated a buy rating 13 days ago

Copying Michael Petusky's trades and holding each position for 1 Year would result in 13.89% of your transactions generating a profit, with an average return of -23.08% per trade.

2 Years

xxx

Success Rate

2/36 ratings generated profit

Average Return

-34.28%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 5.56% of your transactions generating a profit, with an average return of -34.28% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XRAY Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, XRAY has received 5 Buy Ratings, 33 Hold Ratings, and 0 Sell Ratings. XRAY average Analyst price target in the past 3 months is 16.65.

Each month's total comprises the sum of three months' worth of ratings.

XRAY Financial Forecast

XRAY Earnings Forecast

Next quarter’s earnings estimate for XRAY is $0.42 with a range of -$0.04 to $0.49. The previous quarter’s EPS was $0.52. XRAY beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.08% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.

XRAY Sales Forecast

Next quarter’s sales forecast for XRAY is $896.88M with a range of $856.40M to $915.80M. The previous quarter’s sales results were $936.00M. XRAY beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.26% of the time in the same period. In the last calendar year XRAY has Outperformed its overall industry.

XRAY Stock Forecast FAQ

What is XRAY’s average 12-month price target, according to analysts?

Based on analyst ratings, DENTSPLY SIRONA Inc’s 12-month average price target is 16.65.

What is XRAY’s upside potential, based on the analysts’ average price target?

DENTSPLY SIRONA Inc has 16.76% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is XRAY a Buy, Sell or Hold?

DENTSPLY SIRONA Inc has a consensus rating of Hold which is based on 3 buy ratings, 12 hold ratings and 0 sell ratings.

What is DENTSPLY SIRONA Inc’s price target?

The average price target for DENTSPLY SIRONA Inc is 16.65. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $24.00 ,the lowest forecast is $14.00. The average price target represents 16.76% Increase from the current price of $14.26.

What do analysts say about DENTSPLY SIRONA Inc?

DENTSPLY SIRONA Inc’s analyst rating consensus is a Hold. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of XRAY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

XRAY Analyst Ratings

XRAY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering DENTSPLY SIRONA

XRAY Analyst Recommendation Trends

XRAY Financial Forecast

XRAY Earnings Forecast

XRAY Sales Forecast

XRAY Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts